跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法 打開新的分頁/視窗

Elsevier
與我們共同出版

Profile

Hideki Hasegawa

HH

Hideki Hasegawa

National Institute of Infectious Diseases, Japan

Dr. Hideki Hasegawa, M.D., Ph.D., is Director of the Influenza Research Center and WHO Collaborating Centre at NIID, Japan Institute for Health Security. A virologist and pathologist, he focuses on emerging infectious diseases, mucosal immunology, and influenza vaccines. He has characterized pandemic and avian influenza pathology, investigated SFTS, and advanced intranasal inactivated influenza vaccine development. His work on secretory IgA has contributed to mucosal vaccine strategies, including a COVID-19 recombinant protein vaccine. Dr. Hasegawa earned his degrees from Hokkaido University and completed postdoctoral training at The Rockefeller University and University College Dublin.